February 26, 2021February 24, 2021
A Farewell Note to My Beloved Readers
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
So, the time has come. Here I am, three years after I sat down for the first time to write ... Read more
February 15, 2021February 11, 2021
A Light-giver Shares a Lesson in Emotional Honesty
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Have you ever noticed how the people with the most light to give are often those who have endured the ... Read more
February 1, 2021January 27, 2021
Embarking on a New Chapter While Cherishing the Value of Community
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
It’s surreal to ponder that our world has been living through a pandemic for a year now. That we’ve endured ... Read more
December 14, 2020December 9, 2020
Shedding My Sickness While Acknowledging Its Eternal Impact
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Just before the world changed overnight in March, I wrote a column titled “The Paradox of Healing.” In it, I ... Read more
November 16, 2020November 12, 2020
Sometimes Everything Works Out All Right
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
The other day, I chanced upon a poem called “Sometimes” that stopped me in my tracks and penetrated right through ... Read more
September 28, 2020September 24, 2020
Let’s Not Forget the Superheroes
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Lately, in the midst of all the insanity going on in the world and the ensuing, albeit dispiriting, headlines covering ... Read more
September 14, 2020September 10, 2020
Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
For the past week, I have been living in what I can only describe as a state of unrelenting exhaustion. ... Read more
August 31, 2020August 27, 2020
Can a Break From Routine Induce Healing?
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This is a question I found myself pondering the other week as I locked up my little flat and escaped ... Read more
August 17, 2020August 13, 2020
Reflections on My ‘Re-birthday’ and the Past Year of Recovery
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
By the time this column is published, the one-year anniversary of my lifesaving stem cell transplant will have come and ... Read more
July 27, 2020July 23, 2020
This Year Has Taught Me Gratitude
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This week I’ve felt completely at a loss over what to write about. It happens sometimes. Usually there’s something on ... Read more
July 13, 2020July 9, 2020
Total Happiness Is Unobtainable, and That’s OK
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
I recently came to the realization that none of us will ever be totally happy. Upbeat way to start a ... Read more
June 29, 2020June 25, 2020
As I Befriend My Fear of Relapse, Fear Loses Its Power
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Being a cancer survivor is a complicated thing. It’s a lot of conflicting experiences at once. It’s walking down the ... Read more

October 18, 2017October 18, 2017

Incysus Advances T-Cell Therapy into Phase 1 Trial for Blood Cancers

News

Incysus and the University of Alabama at Birmingham (UAB) are advancing the company’s investigational gamma-delta (γδ) T-cell therapy into a Phase 1 clinical study for the treatment of leukemia and lymphoma ... Read more

October 17, 2017October 17, 2017

Primary Care Programs for Cancer Survivors Are Still Lacking, Report Reveals

News

Primary care is not set up to meet the specific healthcare needs of cancer survivors, according to a study by researchers at Rutgers University. The study illustrates how efforts to ... Read more

October 16, 2017October 16, 2017

Remetinostat’s Promising Results in Mycosis Fungoides Patients Presented at EORTC Meeting

News

Topical remetinostat 1% gel can significantly reduce the severity of skin lesions and itching in mycosis fungoides (MF) patients without systemic adverse events, data from a Phase 2 trial show. The ... Read more

October 13, 2017

Four Patients Complete Treatment in Phase 2 Trial of OXS-1550 as Lymphoma and Leukemia Treatment

News

Four lymphoma and leukemia patients have completed treatment with the cancer therapy OXS-1550 (DT2219ARL) in a Phase 2 clinical trial being run by GT Biopharma and the University of Minnesota. ... Read more

October 12, 2017

Clinical Trial Evaluating Resminostat as Maintenance Therapy in CTCL Is Enrolling Participants

News

A Phase 2 trial is currently enrolling participants to evaluate 4SC‘s investigational therapy resminostat as a maintenance therapy for advanced-stage cutaneous T-cell lymphoma (CTCL). The RESMAIN study (NCT02953301) is being conducted at about ... Read more

October 11, 2017

CAR T-cells Targeting CD20-positive Non-Hodgkin’s Lymphoma Safe and Effective, Long-term Study Shows

News

A long-term follow-up study of immunotherapy with CAR T-cells in patients with B-cell non-Hodgkin’s lymphoma with CD20-carrying B-cells show the approach is similar in effectiveness and safety to the more ... Read more

October 10, 2017

Gazyva Reduces Risk of Disease Progression in Follicular Lymphoma Patients, Clinical Trial Finds

News

Interim analysis of the GALLIUM (NCT01332968) clinical trial shows that treatment with Gazyva plus chemotherapy improves progression-free survival in patients with advanced, CD20-positive, untreated follicular lymphoma. The GALLIUM trial set ... Read more

October 9, 2017

Adcetris Induced Durable, Long-term Remission in Nearly Half of Large Cell Lymphoma Patients in Phase 2 Trial

News

More than half of patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL, a particularly aggressive type of lymphoma) who received Adcetris (brentuximab vedotin) during a pivotal Phase 2 ... Read more

A Farewell Note to My Beloved Readers

A Light-giver Shares a Lesson in Emotional Honesty

Embarking on a New Chapter While Cherishing the Value of Community

Shedding My Sickness While Acknowledging Its Eternal Impact

Sometimes Everything Works Out All Right

Let’s Not Forget the Superheroes

Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor

Can a Break From Routine Induce Healing?

Reflections on My ‘Re-birthday’ and the Past Year of Recovery

This Year Has Taught Me Gratitude

Total Happiness Is Unobtainable, and That’s OK

As I Befriend My Fear of Relapse, Fear Loses Its Power